SEC Form 4 · accession 0001179110-18-014209
MEDICINES CO /DE · MDCO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Christopher T Cox
Officer — EVP & Chief Corp. Dev. Officer
Period of report
Dec 20, 2018
Accepted (ET)
Dec 21, 2018 · 7:22 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001113481
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Dec 20, 2018 | P | 113,500 | $17.70 | A | 334,955 | I | See footnote |
| Common Stock | holding | — | — | — | 60,308 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents the weighted average purchase price of the shares purchased ranging from a low of $17.56 to a high of $17.89 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
- F2The shares are held by a trust of which the reporting person is the trustee. The reporting person disclaims beneficial ownership of the shares held by this account except to the extent of his pecuniary interest therein